115 |
Revisiting the well-stirred model of hepatic clearance: QH, CLH and F changing in the same directionRevisiting the well-stirred model of hepatic clearance: QH, CLH and F changing in the same direction
Dong-Seok YimDong-Seok Yim
KMSID: 1082619 Transl Clin Pharmacol. 2016;24(3):115-118. Published online 2016 January 19 DOI: http://dx.doi.org/10.12793/tcp.2016.24.3.115 |
|
119 |
Tips for the choice of initial estimates in NONMEMTips for the choice of initial estimates in NONMEM
Seunghoon Han, Sangil Jeon, Dong-Seok YimSeunghoon Han, Sangil Jeon, Dong-Seok Yim
KMSID: 1082620 Transl Clin Pharmacol. 2016;24(3):119-123. Published online 2016 January 19 DOI: http://dx.doi.org/10.12793/tcp.2016.24.3.119 |
|
124 |
Therapeutic drug monitoring of vancomycin in a patient with Duchenne muscular dystrophy (DMD): A case reportTherapeutic drug monitoring of vancomycin in a patient with Duchenne muscular dystrophy (DMD): A case report
Sang Won Lee, Seonghae Yoon, Kyung-Sang Yu, SeungHwan LeeSang Won Lee, Seonghae Yoon, Kyung-Sang Yu, SeungHwan Lee
KMSID: 1082621 Transl Clin Pharmacol. 2016;24(3):124-126. Published online 2016 January 19 DOI: http://dx.doi.org/10.12793/tcp.2016.24.3.124 |
|
127 |
Rooibos™: Automated schedule broadcast software for clinical pharmacology studiesRooibos™: Automated schedule broadcast software for clinical pharmacology studies
Ji-Hyoung Lee, Woo-Suk Chong, Jong Kwan Park, Tae-Sun Park, Soo-Wan Chae, Min-Gul KimJi-Hyoung Lee, Woo-Suk Chong, Jong Kwan Park, Tae-Sun Park, Soo-Wan Chae, Min-Gul Kim
KMSID: 1082622 Transl Clin Pharmacol. 2016;24(3):127-131. Published online 2016 January 19 DOI: http://dx.doi.org/10.12793/tcp.2016.24.3.127 |
|
132 |
Blood pressure lowering effect of statin drugs with an application to rosuvastatinBlood pressure lowering effect of statin drugs with an application to rosuvastatin
Young-A Heo, Mijeong Son, Kyungsoo ParkYoung-A Heo, Mijeong Son, Kyungsoo Park
KMSID: 1082624 Transl Clin Pharmacol. 2016;24(3):132-136. Published online 2016 January 19 DOI: http://dx.doi.org/10.12793/tcp.2016.24.3.132 |
|
137 |
Comparison of R(+)-α-lipoic acid exposure after R(+)-α-lipoic acid 200 mg and 300 mg and thioctic acid 600 mg in healthy Korean male subjectsComparison of R(+)-α-lipoic acid exposure after R(+)-α-lipoic acid 200 mg and 300 mg and thioctic acid 600 mg in healthy Korean male subjects
Jangsoo Yoon, Seol Ju Moon, Kwang-Ok Lee, Seo Hyun Yoon, In-Jin Jang, Kyung-Sang Yu, SeungHwan LeeJangsoo Yoon, Seol Ju Moon, Kwang-Ok Lee, Seo Hyun Yoon, In-Jin Jang, Kyung-Sang Yu, SeungHwan Lee
KMSID: 1082625 Transl Clin Pharmacol. 2016;24(3):137-142. Published online 2016 January 19 DOI: http://dx.doi.org/10.12793/tcp.2016.24.3.137 |
|
143 |
HLA-A∗24:02/B∗51:01 haplotype and lamotrigine-induced cutaneous adverse drug reactions in KoreansHLA-A∗24:02/B∗51:01 haplotype and lamotrigine-induced cutaneous adverse drug reactions in Koreans
Eun-Young Kim, Ki-Hwan Ji, Hye-Jin Kim, Hye-Eun Jung, Eun-Young Cha, Jae-Gook ShinEun-Young Kim, Ki-Hwan Ji, Hye-Jin Kim, Hye-Eun Jung, Eun-Young Cha, Jae-Gook Shin
KMSID: 1082626 Transl Clin Pharmacol. 2016;24(3):143-146. Published online 2016 January 19 DOI: http://dx.doi.org/10.12793/tcp.2016.24.3.143 |
|
147 |
Development and validation of a HPLC-UV method for 4-(4-chlorophenyl)-4-hydroxypi-peridine (CPHP), a toxic metabolite of haloperidol, in humans: providing in vivo evidence of CYP3A4-mediated CPHP formationDevelopment and validation of a HPLC-UV method for 4-(4-chlorophenyl)-4-hydroxypi-peridine (CPHP), a toxic metabolite of haloperidol, in humans: providing in vivo evidence of CYP3A4-mediated CPHP formation
Ji-Young Park, Jae-Gook ShinJi-Young Park, Jae-Gook Shin
KMSID: 1082627 Transl Clin Pharmacol. 2016;24(3):147-151. Published online 2016 January 19 DOI: http://dx.doi.org/10.12793/tcp.2016.24.3.147 |
|
152 |
Erratum: ClearanceErratum: Clearance
Nick Holford, Dong-Seok YimNick Holford, Dong-Seok Yim
KMSID: 1082628 Transl Clin Pharmacol. 2016;24(3):152-152. Published online 2016 January 19 DOI: http://dx.doi.org/10.12793/tcp.2016.24.3.152 |
|